Le Lézard
Classified in: Health, Science and technology
Subjects: CHI, SVY

Children's Brain Tumor Network Introduces New "CBTN Champions" Giving Tier to Broaden Support for Researchers and Kids


PHILADELPHIA, May 9, 2024 /PRNewswire/ -- The Children's Brain Tumor Network (CBTN), a global leader in pediatric brain tumor research, shares its latest philanthropic initiative: the CBTN "Champions" tier. With an annual giving threshold of $10,000, this new level aims to engage a broader community of supporters in advancing the CBTN mission of transforming the landscape of childhood brain cancer.

This new giving level engages a broader community of supporters to transform the landscape of childhood brain cancer.

CBTN values the input and collaboration of patient foundations, recognizing their vital roles in driving progress. Relationships with these foundations extend beyond philanthropic giving; they represent partnerships built on shared goals and a commitment to keep patients at the center of research. From its inception, patient families have been the driving force behind CBTN, demanding collaboration and innovation. With the Champions level, CBTN aims to further empower patient foundations of all sizes, ensuring they have the resources and knowledge to advocate effectively for research progress.

Every dollar raised for CBTN is instrumental in collecting data for researchers, providing resources to the research community, advocating for further funds, and ultimately improving outcomes for kids with brain tumor diagnoses.

The CBTN Champions tier provides an accessible opportunity for individuals and organizations to actively participate in the CBTN mission. And more partners mean more progress. This tier complements our existing "Executive Council," composed of generous donors who contribute $25,000 or more annually to ensure that supporters of all levels can play a meaningful role in advancing our cause.

"Our Executive Council members and Champions are at the forefront of our vision to transform the landscape of pediatric brain tumor research," explains Gerri Trooskin, CBTN Director of Partnerships. "Their generosity and commitment empower us to push boundaries, foster innovation, and make a difference for families worldwide."

About Children's Brain Tumor Network (CBTN)
Children's Brain Tumor Network (CBTN) is a collaborative research enterprise with the aim to accelerate treatments to accelerate treatments for children with brain tumors. Collectively, the 35 international member institutions comprising CBTN have enrolled more than 5,000 study participants and more than 70,000 biospecimen samples to create the world's most comprehensive repository of childhood brain tumors. The CBTN suite of cloud-based informatics and analytics platforms enables researchers to collaborate in real-time on behalf of children diagnosed with a brain tumor. To learn more about becoming a CBTN Champion, please visit the CBTN partnerships web page.

Emily Reed
[email protected]
239-240-4248

SOURCE Children's Brain Tumor Network


These press releases may also interest you

at 03:05
Owkin, the first end-to-end AI-biotech unicorn that provides best-in-class AI-driven precision drug discovery, development and diagnostics, has announced its expansion into the DACH region (Germany, Austria and Switzerland) following partnerships...

at 03:05
We are excited to share our latest development status. We are pleased to announce that the enrollment of patients in the Phase III clinical trial of DFP-14323 in combination with Afatinib (20 mg/day) versus Afatinib (40 mg/day) alone in stage...

at 02:50
Two hospitals in Belgium are successfully live with the public cloud service from international medical imaging IT and cybersecurity company Sectra (STOCKHOLM: SECT-B). As the first to use Sectra One Cloud in the Benelux countries, the two hospitals...

at 02:03
Barrington James, a global leader in Life Science Recruitment, proudly announces the acquisition of S3 Science Recruitment, a firm renowned for its expertise in drug discovery, medical research, and the broader field of life sciences. Terms of the...

at 02:00
July 3, 2024 Amsterdam, the Netherlands ? Royal Philips , a global leader in health technology, today announced the appointment of Ms Ling Liu as the Chief Region Leader of Philips Greater China, effective immediately. Ms Liu is now a member of...

at 01:39
Hansa Biopharma, "Hansa" , will publish its interim report for January-June 2024 on July 18, 2024. Interested parties may join the Company's quarterly conference call on the same date at 14:00 CEST/8:00 AM EST. The event will be hosted by Søren...



News published on and distributed by: